Feature | February 28, 2014

3-D Printer Creates Transformative Device for Heart Treatment

Igor Efimov, Ph.D., and a team of researchers are developing a custom-fitted, implantable device that can deliver treatment or predict an impending heart attack before a patient shows any physical symptoms. Photo by James Byard, Washington University in St. Louis

Igor Efimov, Ph.D., and a team of researchers are developing a custom-fitted, implantable device that can deliver treatment or predict an impending heart attack before a patient shows any physical symptoms. Photo by James Byard, Washington University in St. Louis

February 28, 2014 — Igor Efimov, Ph.D., from the School of Engineering and Applied Science at Washington University in St. Louis, and an international team of biomedical engineers and materials scientists have created a 3-D elastic membrane made of a soft, flexible, silicon material that is precisely shaped to match the heart's epicardium, or the outer layer of the wall of the heart.

Current technology is two-dimensional and cannot cover the full surface of the epicardium or maintain reliable contact for continual use without sutures or adhesives. The team prints tiny sensors onto the membrane that can precisely measure temperature, mechanical strain and pH, among other markers, or deliver a pulse of electricity in cases of arrhythmia. Those sensors could assist physicians with determining the health of the heart, deliver treatment or predict an impending heart attack before a patient exhibits any physical signs.

The findings were published online in Nature Communications on Feb. 25.

"Each heart is a different shape, and current devices are one-size-fits-all and don't at all conform to the geometry of a patient's heart," says Efimov, the Lucy & Stanley Lopata Distinguished Professor of Biomedical Engineering. "With this application, we image the patient's heart through MRI [magnetic resonance imaging] or CT [computed tomography], then computationally extract the image to build a 3-D model that we can print on a 3-D printer. We then mold the shape of the membrane that will constitute the base of the device deployed on the surface of the heart."

Ultimately, the membrane could be used to treat diseases of the ventricles in the lower chambers of the heart or could be inserted inside the heart to treat a variety of disorders, including atrial fibrillation, which affects 3-5 million patients in the United States.

"Currently, medical devices to treat heart rhythm diseases are essentially based on two electrodes inserted through the veins and deployed inside the chambers," Efimov says. "Contact with the tissue is only at one or two points, and it is at a very low resolution. What we want to create is an approach that will allow you to have numerous points of contact and to correct the problem with high-definition diagnostics and high-definition therapy."

Co-leading the team with Efimov is John Rogers, Ph.D., the Swanlund chair and professor of materials science and engineering and director of the F. Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign. Rogers, who developed the transfer printing technique, developed the sensors using semiconductor materials including silicon, gallium arsenide and gallium nitride, along with metals, metal oxides and polymers.

Recently, Google announced its scientists had developed a type of contact lens embedded with sensors that could monitor glucose levels in patients with diabetes. Efimov says the membrane his team has developed is a similar idea, though much more sophisticated. "Because this is implantable, it will allow physicians to monitor vital functions in different organs and intervene when necessary to provide therapy," he says. "In the case of heart rhythm disorders, it could be used to stimulate cardiac muscle or the brain, or in renal disorders, it would monitor ionic concentrations of calcium, potassium and sodium."

Efimov says the membrane could even hold a sensor to measure troponin, a protein expressed in heart cells and is a hallmark of a heart attack. Analysis for troponin is standard of care for patients with suspected heart attacks.

Ultimately, such devices will be combined with ventricular assist devices (VAD), Efimov says. "This is just the beginning. Previous devices have shown huge promise and have saved millions of lives. Now we can take the next step and tackle some arrhythmia issues that we don't know how to treat."

For more information: www.nature.com/ncomms/2014/140225/ncomms4329/full/ncomms4329.html

Related Content

3-D modeling, reconstructed hearts, child heart transplants, AHA Scientific Sessions 2015
News | Advanced Visualization| November 23, 2015
A new 3-D computer modeling system may significantly improve a surgeon’s ability to select the best-sized donor heart...
Technology | Cardiac Diagnostics| November 20, 2015
Boston Heart Diagnostics announced the launch of StatinSmart, an at-home saliva laboratory developed test that analyzes...
ContextVision, RSNA 2015, ultrasound image enhancement, 3-D/4-D

Liver ultrasound enhanced with US PlusView. Image courtesy of ContextVision.

Technology | Ultrasound Imaging| November 20, 2015
At this year’s scientific assembly and annual meeting of the Radiological Society of North America (RSNA),...
Rijuven, CardioSleeve for Pediatrics, FDA clearance, stethoscopes

Image courtesy of Rijuven

Technology | Stethoscopes| November 19, 2015
Rijuven announced the launch of CardioSleeve for Pediatrics, the first U.S. Food and Drug Administration (FDA)-cleared...
iRhythm Technologies, ZIO continuous cardiac monitoring service, myZIO app, irregular heartbeat symptoms, reporting

Image courtesy of iRhythm Technologies

Technology | ECG Monitoring Services| November 19, 2015
iRhythm Technologies Inc. announced the launch of new patient engagement tools to enhance the diagnosis of cardiac...
News | Blood Testing| November 18, 2015
Konica Minolta Inc. announced that it has developed the SPFS Immunoassay System, capable of highly sensitive...
wearable Holter monitors, iRhythm, ziopatch, zio patch

iRhythm Technologies Zio Patch was among the first of a new generation of simplified, wearable Holter monitors designed to increase ease of use and patient compliance to increase detection of arrhythmias that may lead to stroke.

Feature | Holter Monitoring Systems| November 16, 2015 | Judy Lenane, RN, MHA
One-third of ischemic strokes are classified as cryptogenic.
angina, abnormal heart blood flow, female-pattern heart disease, Cedars-Sinai Heart Institute study, AHA Scientific Sessions
News | Cardiac Diagnostics| November 13, 2015
Chest pain in female-pattern heart disease is linked with abnormal heart blood flow, a new Cedars-Sinai Heart Institute...

Cardiologists using the Philips spectral CT software to view a spectral CT image reconstruction at various energy levels.

Feature | CT Angiography (CTA)| November 12, 2015 | Dave Fornell
Computed tomography has seen rapid growth in all segments of medicine over the past two decades, and recent advances
obese kids, eight years old, heart disease, MRI, Linyuan Jing
News | Cardiac Diagnostics| November 11, 2015
Imaging tests of obese children — some as young as 8 years old — showed signs of significant heart disease and heart...
Overlay Init